— texasreader (@livenlearn2015) May 2, 2017
One Step for Mannkind and a Huge Inhalation for People with Diabetes
Taking Control Of Your Diabetes / Published on Feb 7, 2017
— johnhindepost (@johnhindepost) July 12, 2016
Deciphering the Data on Inhaled Insulin: Implications for Practice
Super rapid acting insulin and inhaled Afrezza
Jay Skyler MD PhD discusses the prandial problem and the need for super rapid acting insulin, such as MannKind’s inhaled Afrezza
Ask Joslin: Inhalable Insulin
Dr. Robert Gabbay, Chief Medical Officer at Joslin Diabetes Center, answers some of your questions about the inhalable insulin on the market today.
Artificial Pancreas — Ultra-Rapid-Acting Inhaled Insulin
JDRF, Sansum Diabetes Research Institute, and the College of Engineering at University of California, Santa Barbara (UCSB) are pleased to announce the first successful clinical research trial using the artificial pancreas in conjunction with ultra-rapid-acting inhaled insulin.
Mannkind ADCOM public testimony